Question to the Department of Health and Social Care:

To ask Her Majesty's Government how cures and treatments in the NHS are being developed to reduce the danger in hospitals of anti-microbial resistance.

The UK Antimicrobial Resistance (AMR) Strategy published in 2013 set out the key actions needed to tackle AMR: preventing infections, making appropriate use of the treatments available, and promoting the development of new treatments. In 2016 the government announced ambitions to halve healthcare-associated Gram-negative bloodstream infections and inappropriate prescribing of antimicrobials by 2020-2021. To promote the development of new drugs, diagnostics and alternative treatments we have established unprecedented levels of research collaboration, together with increased investment, including the £50 million Global AMR Innovation Fund. The Government is committed to working with the global finance and health community to develop a global system that rewards companies that develop new, successful antibiotics and make them available to all who need them.